Overview

Gender

male

Charles J. Dockendorff is the Member of the Board of Directors at Boston Scientific Corporation since April 2015.

Charles is also presently serving as a Member of the Board of Directors of Haemonetics Corporation and Keysight Technologies.

Previously, Charles was Executive Vice President and Chief Financial Officer (CFO) at Covidien plc, a position he has held frpm 1995 to 2015. In this position, Charles was responsible for the Company’s financial management and activities, including Corporate Accounting, Tax, Treasury, Financial Planning and Investor Relations, as well as Internal Audit and Information Services. The financial leadership for Covidien’s three business segments also report to him.

Charles joined the Kendall Healthcare Products Company, the foundation of the Covidien (formerly known as Tyco Healthcare) business, in 1989 as Controller and he was named Vice President and Controller of Kendall in 1994. In 1995, Charles was appointed Chief Financial Officer of Covidien and helped the Company grow from $600 million in sales to the diverse $10 billion healthcare products leader it is today.

Before joining Covidien and its predecessors, Charles was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and the Chief Financial Officer of Infrared Industries, Inc.

In addition, Charles worked as an Accountant for Arthur Young & Company (now Ernst & Young) and the General Motors Corporation.

A Certified Public Accountant, Charles has a Bachelor’s degree in Business Administration/Accounting from the University of Massachusetts and a Master of Science degree in Finance from Bentley College (Massachusetts).